The Growing Importance of Biomarker Testing Across North America's Oncology Landscape
The Oncology Companion Diagnostics Market in North America is witnessing steady growth as healthcare providers increasingly utilize companion diagnostic tests to identify cancer biomarkers and guide the selection of targeted therapies. Growing adoption of personalized oncology, increasing investment in cancer research, expanding use of molecular testing, and advances in genomic...
0 Comments 0 Shares 7 Views 0 Reviews